全文获取类型
收费全文 | 1211篇 |
免费 | 60篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 83篇 |
妇产科学 | 18篇 |
基础医学 | 130篇 |
口腔科学 | 23篇 |
临床医学 | 86篇 |
内科学 | 278篇 |
皮肤病学 | 31篇 |
神经病学 | 62篇 |
特种医学 | 84篇 |
外科学 | 122篇 |
综合类 | 30篇 |
一般理论 | 2篇 |
预防医学 | 29篇 |
眼科学 | 40篇 |
药学 | 101篇 |
中国医学 | 2篇 |
肿瘤学 | 132篇 |
出版年
2023年 | 5篇 |
2022年 | 16篇 |
2021年 | 41篇 |
2020年 | 9篇 |
2019年 | 28篇 |
2018年 | 24篇 |
2017年 | 17篇 |
2016年 | 29篇 |
2015年 | 23篇 |
2014年 | 39篇 |
2013年 | 60篇 |
2012年 | 75篇 |
2011年 | 73篇 |
2010年 | 30篇 |
2009年 | 32篇 |
2008年 | 59篇 |
2007年 | 56篇 |
2006年 | 63篇 |
2005年 | 67篇 |
2004年 | 77篇 |
2003年 | 56篇 |
2002年 | 53篇 |
2001年 | 29篇 |
2000年 | 24篇 |
1999年 | 26篇 |
1998年 | 8篇 |
1995年 | 7篇 |
1994年 | 7篇 |
1992年 | 16篇 |
1991年 | 19篇 |
1990年 | 14篇 |
1989年 | 16篇 |
1988年 | 12篇 |
1987年 | 18篇 |
1986年 | 18篇 |
1985年 | 13篇 |
1984年 | 8篇 |
1983年 | 12篇 |
1982年 | 6篇 |
1980年 | 6篇 |
1979年 | 11篇 |
1978年 | 11篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1975年 | 6篇 |
1974年 | 7篇 |
1973年 | 4篇 |
1972年 | 6篇 |
1970年 | 6篇 |
1969年 | 6篇 |
排序方式: 共有1273条查询结果,搜索用时 15 毫秒
71.
Ogbogu P Fleischer AB Brodell RT Bhalla G Draelos ZD Feldman SR 《Archives of dermatology》2001,137(2):151-154
OBJECTIVE: To describe physicians' and patients' reasons for participating in office-based sales of dermatologic products. DESIGN: Survey data on the attitudes, opinions, and beliefs of dermatologists and their patients were analyzed. SETTING: A market research study of office-based selling. PARTICIPANTS: Thirty dermatologists involved in direct selling from the office, 20 dermatologists not involved in direct selling, 22 patients who purchase products from their dermatologists' offices, and 25 office managers. MAIN OUTCOME MEASURE: The hypotheses of this study were formulated after the market research study had been done. The main outcome measure was the physicians' and patients' reported reasons for patients purchasing skin care products from dermatologists rather than from retail stores. RESULTS: "Trust" was the most frequent reason cited by physicians for patient purchases, while "physician knowledge" was the most frequent reason cited by the purchasing patients. The most common location to display the products was the waiting room (20 [67%] of the physicians). The most common types of products sold included glycolic acid products (15 [50%]), moisturizers (13 [43%]), sunscreens (12 [40%]), and alpha-hydroxy acid products other than glycolic acid (9 [30%]). CONCLUSION: The interaction between physicians who sell products in their offices and their patients is highlighted by 2 key elements of the physician-patient relationship: trust and physician knowledge. 相似文献
72.
73.
K N Bhalla G N Kumar U K Walle A M Ibrado T Javed R K Stuart C Reed S G Arbuck T Walle 《Clinical cancer research》1999,5(7):1723-1730
A Phase I and pharmacological study of paclitaxel administered as an outpatient, 3-h i.v. infusion just before a 5-day regimen of daily cisplatinum (CP) and a continuous infusion of 5-fluorouracil (5-FU) was performed in patients with advanced solid tumors. A secondary objective was to determine the objective response rate to this regimen. Forty-two patients were enrolled and were evaluable for toxicities. Eighteen patients were previously untreated, whereas the rest had received prior treatment with radiation (J. H. Schiller et al., J. Clin. Oncol., 12: 241-248, 1994), chemotherapy (M. J. Kennedy et al., Clin. Cancer Res., 4: 349-356, 1998), or both modalities (J. H. Schiller et al., J. Clin. Oncol., 12: 241-248, 1994). The paclitaxel dose was escalated from 100-135-170-200-225 to 250 mg/m2, whereas i.v. 5-FU and CP doses were fixed at 1.0 g/m2/day continuous infusion and 20 mg/m2/day, respectively, daily for 5 days. Granulocyte colony-stimulating factor (G-CSF; 5 microg/kg/day) was administered s.c. from day 6, routinely after 250 mg/m2 dose of paclitaxel or after a lower dose of paclitaxel if ANC <500/microl or febrile neutropenia was observed. Patients were treated every 28 days. Plasma and urine samples were collected to determine the pharmacokinetics of paclitaxel. In previously untreated patients, the maximally tolerated dose of paclitaxel in the drug regimen was determined to be 170 mg/m2 without and 250 mg/m2 with G-CSF support. At the higher dose level, mucositis and thrombocytopenia were dose-limiting. In previously treated patients, these toxicities were observed at all dose levels of paclitaxel > or =135 mg/m2. With increasing doses of paclitaxel, a disproportionate increase in the peak concentrations, as well as the area under plasma concentration time-curve, was seen. This nonlinearity was due to saturable total body clearance and volume of distribution of paclitaxel (P < 0.001). The apparent plasma elimination half-life was unaffected by the dose of paclitaxel. CP and 5-FU had no apparent effect on the metabolism of paclitaxel. Among 32 patients evaluable for response, 22 demonstrated an objective response, including five complete remissions. Therefore, a regimen of 3-h infusion of 250 mg/m2 paclitaxel before CP and FU is tolerable with G-CSF (as above) support in previously untreated patients. The regimen also seems to be highly active against breast and esophageal cancers. 相似文献
74.
A study of twins 总被引:1,自引:0,他引:1
75.
76.
Newcomb E. W. Bhalla Sandhya K. Parrish Clarissa L. Hayes Roberta L. Cohen Henry Miller Douglas C. 《Acta neuropathologica》1997,94(4):369-375
bcl-2 protein expression was characterized in a series of 58 astrocytomas from 21 pediatric and 37 adult patients. As part
of a continuing attempt to define relevant prognostic factors which may predict clinical outcome, we have determined the impact
of bcl-2 accumulation in malignant astrocytes on the length of patient survival. Aberrant overexpression of bcl-2 protein
in tumor cells was detected in 57% (12 of 21) of pediatric and 73% (27 of 37) of the adult cases. Among pediatric patients,
the median survival in months showed no relationship with the incidence of bcl-2-positive tumors. Among the adult patients,
a favorable prognostic indicator was low-tumor grade (P = 0.05). bcl-2-positive tumors occurred with similar frequencies in WHO grades III and IV of malignancy. When bcl-2 expression
in tumor cells was tested as a variable to predict for patient survival, the 6 patients without bcl-2 expression among 23
adult patients with grade IV tumors had a shorter median survival. The same 58 tumors had been previously analyzed for alterations of p53: 4 pediatric and 16 adult tumors had p53 gene mutations. There was no significant difference in median survival related to p53 gene status. There was no relationship between bcl-2 expression and p53 gene status: approximately equal numbers of tumors with either wild-type or mutant p53 were bcl-2 negative or bcl-2 positive.
bcl-2 expression is high (40–100%) among other tumors of the central nervous system which also show low malignant potential.
Up-regulation of bcl-2 in malignant astrocytes or constitutive expression in some tumor types may be a factor leading to a
more favorable clinical outcome.
Received: 27 January 1997 / Revised: 21 March 1997 / Accepted: 28 March 1997 相似文献
77.
78.
Susheel Kumar Navneet Sharma Aman Sharma Sushil Mahi Ashish Bhalla Subhash Varma 《Clinical rheumatology》2009,28(Z1):69-71
Systemic lupus erythematosus (SLE) is a multisystem, autoimmune connective tissue disorder. Neuropsychiatric SLE (NPSLE) has
varied clinical and radiological manifestations. Clinical manifestations range from subtle abnormalities of neurocognitive
functions and mood changes to overt psychiatric or neurological manifestations such as seizures, stroke, and psychosis. Magnetic
resonance imaging (MRI) may show various types of abnormalities. Cerebral white matter lesions are most common (60–86%). Here,
we are discussing a young female who presented with alteration of sensorium and right-sided hemiparesis, and MRI of the brain
showed extensive involvement of brainstem in the form of possible demyelination. 相似文献
79.
Mark M Aloysius Alastair J Mc Kechnie Richard A Robins Chandan Verma Jennifer M Eremin Farzin Farzaneh Nagy A Habib Joti Bhalla Nicola R Hardwick Sukchai Satthaporn Thiagarajan Sreenivasan Mohammed El-Sheemy Oleg Eremin 《Journal of translational medicine》2009,7(1):1-23
Background
Optimal techniques for DC generation for immunotherapy in cancer are yet to be established. Study aims were to evaluate: (i) DC activation/maturation milieu (TNF-α +/- IFN-α) and its effects on CD8+ hTERT-specific T cell responses to class I epitopes (p540 or p865), (ii) CD8+ hTERT-specific T cell responses elicited by vaccination with class I alone or both class I and II epitope (p766 and p672)-pulsed DCs, prepared without IFN-α, (iii) association between circulating T regulatory cells (Tregs) and clinical responses.Methods
Autologous DCs were generated from 10 patients (HLA-0201) with advanced cancer by culturing CD14+ blood monocytes in the presence of GM-CSF and IL-4 supplemented with TNF-α [DCT] or TNF-α and IFN-α [DCTI]. The capacity of the DCs to induce functional CD8+ T cell responses to hTERT HLA-0201 restricted nonapeptides was assessed by MHC tetramer binding and peptide-specific cytotoxicity. Each DC preparation (DCT or DCTI) was pulsed with only one type of hTERT peptide (p540 or p865) and both preparations were injected into separate lymph node draining regions every 2–3 weeks. This vaccination design enabled comparison of efficacy between DCT and DCTI in generating hTERT peptide specific CD8+ T cells and comparison of class I hTERT peptide (p540 or p865)-loaded DCT with or without class II cognate help (p766 and p672) in 6 patients. T regulatory cells were evaluated in 8 patients.Results
(i) DCTIs and DCTs, pulsed with hTERT peptides, were comparable (p = 0.45, t-test) in inducing peptide-specific CD8+ T cell responses. (ii) Class II cognate help, significantly enhanced (p < 0.05, t-test) peptide-specific CD8+T cell responses, compared with class I pulsed DCs alone. (iii) Clinical responders had significantly lower (p < 0.05, Mann-Whitney U test) T regs, compared with non-responders. 4/16 patients experienced partial but transient clinical responses during vaccination. Vaccination was well tolerated with minimal toxicity.Conclusion
Addition of IFN-α to ex vivo monocyte-derived DCs, did not significantly enhance peptide-specific T cell responses in vivo, compared with TNF-α alone. Class II cognate help significantly augments peptide-specific T cell responses. Clinically favourable responses were seen in patients with low levels of circulating T regs. 相似文献80.
The epithelial Na+ channel (ENaC) transports Na+ across tight epithelia, including the distal nephron. Different paradigms of ENaC regulation include extrinsic and intrinsic factors that affect the expression, single-channel properties, and intracellular trafficking of the channel. In particular, recent discoveries highlight new findings regarding proteolytic processing, ubiquitination, and recycling of the channel. Understanding the regulation of this channel is critical to the understanding of various clinical phenomena, including normal physiology and several diseases of kidney and lung epithelia, such as blood pressure (BP) control, edema, and airway fluid clearance. Significant progress has been achieved in this active field of research. Although ENaC is classically thought to be a mediator of BP and volume status through Na+ reabsorption in the distal nephron, several studies in animal models highlight important roles for ENaC in lung pathophysiology, including in cystic fibrosis. The purpose of this review is to highlight the various modes and mechanisms of ENaC regulation, with a focus on more recent studies and their clinical implications. 相似文献